MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 30, 2004; DOI: 10.1124/mol.104.001487


0026-895X/04/6604-880-889$20.00
Mol Pharmacol 66:880-889, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.001487v1
66/4/880    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capra, V.
Right arrow Articles by Rovati, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capra, V.
Right arrow Articles by Rovati, G. E.

Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling

Valérie Capra, Alessio Veltri, Chiara Foglia, Luca Crimaldi, Aïda Habib, Marco Parenti, and G. Enrico Rovati

Laboratory of Molecular Pharmacology, Section of Theoretical and Receptor Pharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy (V.C., A.V., C.F., G.E.R.); Institut National de la Sante et de la Recherche Medicale U348, IFR Circulation-Paris-Nord, Hôpital Lariboisière, Paris, France (V.C., A.H.); Departments of Biochemistry and Internal Medicine, American University of Beirut, Beirut, Lebanon (A.H.); and Department of Experimental and Environmental Medicine and Medical Biotechnologies, University of Milan Bicocca, Milan, Italy (L.C., M.P.)

The presence of highly conserved amino acid stretches in G protein-coupled receptors (GPCRs) usually predicts an important role in receptor function. Considerable attention has therefore been focused on the involvement of the highly conserved Glu/Asp-Arg-Tyr (E/DRY) motif at the cytoplasmic end of transmembrane domain 3 in the regulation of GPCR conformational states and/or the mediation of G protein activation. In the present study, we investigated the role of Glu129 and Arg130 in the ERY of thromboxane A2 receptor {alpha} (TP{alpha}) in transfected human embryonic kidney 293 cells. We show that no conservative or nonconservative substitutions of Glu129 and Arg130 generated a constitutively active TP{alpha} mutant, but a nonconservative mutation of Arg130 (R130V) yielded a mutant receptor with significantly impaired 9,11-dideoxy-9{alpha},11{alpha}-methanoepoxy-prosta-5Z,13E-dien-1-oic acid (U46619)-induced accumulation of inositol phosphates (IPs). This loss-of-function phenotype seems to be caused by the uncoupling of the TP{alpha} receptor from Gq, as demonstrated by the loss of high-affinity agonist binding, and not by receptor internalization, as shown by localization studies with the R130V-green fluorescent protein fusion protein. It is interesting to note that U46619-induced activation of the nonconservative E129V mutant stimulated the production of IPs with a ~10-fold lower EC50 and a ~2-fold higher Emax than in the wild-type receptor. Collectively, these data demonstrate that, unlike other GPCRs, mutations of Glu129 do not induce constitutive activity, whereas Arg130 is involved in G protein coupling or recognition, and they suggest the existence within class A GPCRs of at least two different subclasses that make different uses of the highly conserved E/DRY motif.


Received April 21, 2004; accepted June 30, 2004

Address correspondence to: Dr. Valérie Capra, Laboratory of Molecular Pharmacology, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. E-mail: valerie.capra{at}unimi.it




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. Peverelli, A. G. Lania, G. Mantovani, P. Beck-Peccoz, and A. Spada
Characterization of Intracellular Signaling Mediated by Human Somatostatin Receptor 5: Role of the DRY Motif and the Third Intracellular Loop
Endocrinology, July 1, 2009; 150(7): 3169 - 3176.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. D. Proulx, B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette, and R. Leduc
Mutational Analysis of the Conserved Asp2.50 and ERY Motif Reveals Signaling Bias of the Urotensin II Receptor
Mol. Pharmacol., September 1, 2008; 74(3): 552 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Case, E. Sharp, T. Benned-Jensen, M. M. Rosenkilde, N. Davis-Poynter, and H. E. Farrell
Functional Analysis of the Murine Cytomegalovirus Chemokine Receptor Homologue M33: Ablation of Constitutive Signaling Is Associated with an Attenuated Phenotype In Vivo
J. Virol., February 15, 2008; 82(4): 1884 - 1898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Tokunaga, B. Matsuura, M. Dong, L. J. Miller, T. Ueda, S. Furukawa, Y. Hiasa, and M. Onji
Mutational analysis of predicted intracellular loop domains of human motilin receptor
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G460 - G466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Angelova, F. Fanelli, and D. Puett
Contributions of Intracellular Loops 2 and 3 of the Lutropin Receptor in Gs Coupling
Mol. Endocrinol., January 1, 2008; 22(1): 126 - 138.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Binet, B. Duthey, J. Lecaillon, C. Vol, J. Quoyer, G. Labesse, J.-P. Pin, and L. Prezeau
Common Structural Requirements for Heptahelical Domain Function in Class A and Class C G Protein-coupled Receptors
J. Biol. Chem., April 20, 2007; 282(16): 12154 - 12163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. E. Rovati, V. Capra, and R. R. Neubig
The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Mol. Pharmacol., April 1, 2007; 71(4): 959 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Buccellati, A. Sala, G. Rossoni, V. Capra, G. E. Rovati, A. Di Gennaro, G. Folco, S. Colli, and C. Casagrande
Pharmacological Characterization of 2NTX-99 [4-Methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a Potential Antiatherothrombotic Agent with Antithromboxane and Nitric Oxide Donor Activity in Platelet and Vascular Preparations
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 830 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Capra, S. Ravasi, M. R. Accomazzo, S. Citro, M. Grimoldi, M. P. Abbracchio, and G. E. Rovati
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation
J. Cell Sci., December 1, 2005; 118(23): 5625 - 5636.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. R. Hawtin
Charged Residues of the Conserved DRY Triplet of the Vasopressin V1a Receptor Provide Molecular Determinants for Cell Surface Delivery and Internalization
Mol. Pharmacol., October 1, 2005; 68(4): 1172 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. A. Flanagan
A GPCR That Is Not "DRY"
Mol. Pharmacol., July 1, 2005; 68(1): 1 - 3.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. Rosenkilde, T. N. Kledal, and T. W. Schwartz
High Constitutive Activity of a Virus-Encoded Seven Transmembrane Receptor in the Absence of the Conserved DRY Motif (Asp-Arg-Tyr) in Transmembrane Helix 3
Mol. Pharmacol., July 1, 2005; 68(1): 11 - 19.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics